Hyperhomocysteinaemia and parameters of antioxidative defence in Tunisian patients with coronary heart disease

Annals of Clinical Biochemistry

Volumn 45, Issue 2, 2008, Pages 193-198

  Kerkeni, Mohsen ^a   Added, Faouzi ^b   Farhat, Mohamed Ben ^b   Miled, Abdelhedi ^c   Trivin, François ^d   Maaroufi, Khira ^a  

^a UNIVERSITY OF MONASTIR   (Tunisia)

^b FATTOUMA BOURGUIBA UNIVERSITY HOSPITAL   (Tunisia)

^c FARHAT HACHED HOSPITAL   (Tunisia)

^d UNIVERSITÉ DE TOURS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTATHIONE PEROXIDASE; HOMOCYSTEINE; SUPEROXIDE DISMUTASE; ZINC;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; CHEMOLUMINESCENCE; COLORIMETRY; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; DISEASE SEVERITY; ENZYME ACTIVITY; FEMALE; HUMAN; HYPERHOMOCYSTEINEMIA; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TUNISIA; ZINC BLOOD LEVEL;

ANTIOXIDANTS; CORONARY DISEASE; FEMALE; GLUTATHIONE PEROXIDASE; HUMANS; HYPERHOMOCYSTEINEMIA; MALE; MIDDLE AGED; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; SUPEROXIDE DISMUTASE; TUNISIA; ZINC;

EID: 44249091608     PISSN: 00045632     EISSN: 00045632     Source Type: Journal    
DOI: 10.1258/acb.2007.007066     Document Type: Article

References (49)

1. Ben Romdhane H, Bougatef S, Shiri H, et al. The first Tunisian cardiovascular diseases register: processes and results. Rev Epidemiol Sante Publique 2004;52:558-64
2. Kerkeni M, Addad F, Chauffert M, et al. Hyperhomocysteinaemia, methylenetetrahydrofolate reductase polymorphism and risk of coronary artery disease. Ann Clin Biochem 2006;43:200-6
3. Kerkeni M, Addad F, Chauffert M, et al. Hyperhomocysteinemia, endothelial nitric oxide synthase polymorphism, and risk of coronary artery disease. Clin Chem 2006;52:53-8
4. Kerkeni M, Addad F, Chauffert M, et al. Hyperhomocysteinemia, paraoxonase activity and risk of coronary artery disease. Clin Biochem 2006;39:821-5
5. Forsberg L, de Faire U, Morgenstern R. Oxidative stress, human genetic variation and disease. Arch Biochem Biophys 2001;389:84-93
6. Flohe L. Glutathione peroxidase. Basic Life Sci 1988;49:663-8
7. Sies H. Glutathione and its role in cellular functions. Free Radic Biol Med 1999;27:916-21
8. Forgione MA, Cap A, Liao R, Moldovan NI, Lim CC. Heterozygous cellular glutathione peroxidase deficiency in the mouse: abnormalities in vascular and cardiac function and structure. Circulation 2002;106:1154-8
9. Fukai T, Folz RJ, Landmesser U, Harrison DG. Extracellular dismutase and cardiovascular disease. Cardiovasc Res 2002;55:239-49
10. Wayner DD, Burton GW, Ingold KU, Locke S. Quantitative measurement of the total, peroxyl radical-trapping antioxidant capability of human blood plasma by controlled peroxidation. The important contribution made by plasma proteins. FEBS Lett 1985;187:33-7
11. Cao G, Prior RL. Measurement of oxygen radical absorbance capacity in biological samples. Methods Enzymol 1999;299:50-62
12. Rice-Evans C, Miller NJ. Total antioxidant status in plasma and body fluids. Methods Enzymol 1994;234:279-93
13. Young IS, Woodside JV. Antioxidants in health and disease. J Clin Pathol 2001;54:176-86
14. Lantos J, Roth E, Czopf L, Nemes J, Gal I. Monitoring of plasma total antioxidant status in different diseases. Acta Chir Hung 1997;36:188-9
15. Nojiri S, Daida H, Mokuno H, et al. Association of serum antioxidant capacity with coronary artery disease in middle-aged men. Jpn Heart J 2001;42:677-90
16. Colak E, Majkic-Singh N, Stankovic S, et al. Parameters of antioxidative defence in type 2 diabetic patients with cardiovascular complications. Ann Med 2005;37:613-20
17. Subramanyam G, Vijiaya J. Trace Elements in Cardiovascular Disease. Tirupati, India: S V Medical College, 1997:15-66
18. Uza G, Vlaicu R. Serum zinc and copper in patients with atherosclerosis and thromboangitis obliterans. Biol Trace Elem Res 1989;20:197-206
19. Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 1967;70:158-69
20. Miller NJ, Rice-Evans C, Davies MJ, Gopinathan V, Milner A. A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates. Clin Sci 1993;84:407-12
21. Makino T, Saito M, Horiguchi D, Kina K. A highly sensitive colorimetric determination of serum zinc using water soluble pyridylazo dye. Clin Chim Acta 1982;120:127-35
22. Dogru-Abdosoglu S, Kanbagli O, Bulur H, et al. Lipid peroxides and antioxidant status in serum of patients with angiographically defined coronary atherosclerosis. Clin Biochem 1999;32:671-2
23. Markovic S, Dordevic J, Majkic-Singh N, et al. The importance of antioxidant enzyme and total antioxidant status of patients with acute myocardial infarction on thrombolytic therapy. Clin Lab 2000;46:495-9
24. Tosukhowong P, Sangwatanaroi S, Jatuporn S, et al. The correlation between markers of oxidative stress and risk factors of coronary artery disease in Thai patients. Clin Hemorheol Microcirc 2003;29:321-9
25. Ruef J, Marz W, Winkelmann BR. Markers for endothelial dysfunction, but not markers for oxidative stress correlate with classical risk factors and the severity of coronary artery disease. (A subgroup analysis from the Ludwigshafen Risk and Cardiovascular Health Study). Scand Cardiovasc J 2006;40:274-9
26. Ghiselli A, Serafini M, Natella F, Scaccini C. Total antioxidant capacity as a tool to assess redox status: critical view and experimental data. Free Radic Biol Med 2000;29:1106-14
27. Erel O. A novel automated method to measure total antioxidant response against potent free radical reactions. Clin Biochem 2004;37:112-19
28. Yegin A, Yegin H, Aliciguzed Y, Deger N, Semiz E. Erythrocyte selenium-glutathione peroxidase activity is lower in patients with coronary atherosclerosis. Jpn Heart J 1997;38:793-8
29. Starkebaum G, Harlan JM. Endothelial cell injury due to copper-catalysed hydrogen peroxide generation from homocysteine. J Clin Invest 1986;77:1370-6
30. Sawle P, Foresti R, Green CJ, Motterlini R. Homocysteine attenuates endothelial haem oxygenase-1 induction by nitric oxide (NO) and hypoxia. FEBS Lett 2001;508:403-6
31. Outinen PA, Sood SK, Pfeifer SI, et al. Homocysteine induced endoplasmic reticulum stress and growth arrest leads to specific changes in gene expression in human vascular endothelial cells. Blood 1999;94:959-67
32. Upchurch GR, Welch GN, Fabian AN, et al. Homocysteine decrease bioavialable nitric oxide by a mechanism involving glutathione peroxidase. J Biol Chem 1997;272:17012-17
33. Dayal S, Brown KL, Weydert CJ, et al. Deficiency of glutathione peroxidase-1 sensitizes hyperhomocysteinemic mice to endothelial dysfunction. Arterioscler Thromb Vasc Biol 2002;22:1996-2002
34. Weiss N, Zhang YY, Heydrick S, Bierl C, Loscalzo J. Overexpression of cellular glutathione peroxidase rescues homocysteine induced endothelial dysfunction. Proc Natl Acad Sci USA 2001;98:12503-8
35. Omar HA, Cherry PD, Mortelliti MP, Burke-Wolin T, Wolin MS. Inhibition of coronary artery superoxide dismutase attenuates endothelium-dependent and independent nitrovasodilator relaxation. Circ Res 1991;69:601-8
36. Lynch SM, Frei B, Morrow JD, et al. Vascular superoxide dismutase deficiency impairs endothelial vasodilator function through direct inactivation of nitric oxide and increased lipid peroxidation. Arterioscler Thromb Vasc Biol 1997;17:2975-81
37. Nihei S, Tasaki H, Yamashita K, et al. Hyperhomocysteinemia is associated with human coronary atherosclerosis through the reduction of the ratio of endothelium bound to basal extracellular superoxide dismutase. Circ J 2004;68:822-8
38. Chu Y, Iida S, Lund DD, et al. Gene transfer of extracellular superoxide dismutase reduces arterial pressure in spontaneously hypertensive rats: role of heparin-binding domain. Circ Res 2003;92:461-8
39. Watanabe Y, Chu Y, Andresen JJ, Nakane H, Faraci F, Heistad DD. Gene transfer of extracellular superoxide dismutase reduces cerebral vasospasm after subarachnoid haemorrhage. Stroke 2003;34:434-40
40. Juul K, Tybjarg-Hansen A, Marklund S, et al. Genetically reduced antioxidative protection and increased ischemic heart disease risk: The Copenhagen City Heart Study. Circulation 2004;109:59-65
41. Yamamoto M, Hara H, Adachi T. Effects of homocysteine on the binding of extracellular-superoxide dismutase to the endothelial cell surface. FEBS Lett 2000;486:159-62
42. Nonaka H, Tsujino T, Watari Y, Emoto N, Yokoyama M. Taurine prevent the decrease in expression and secretion of extracellular superoxide dismutase induced by homocysteine: amelioration of homocysteine-induced endoplasmic reticulum stress by taurine. Circulation 2001;104:1165-70
43. Crane FL, Sum EE. The essential functions of coenzyme Q. Clin Invest 1993;71:55-9
44. Niklowitz P, Sonnenschein A, Janetzky B, Andler W, Menke T. Enrichment of coenzyme Q10 in plasma and blood cells: defense against oxidative damage. Int J Biol Sci 2007;3:257-62
45. Rundek T, Naini A, Sacco R, Coates K, DiMauro S. Atorvastatin decreased the coenzyme Q10 level in the blood of patients at risk for cardiovascular disease and stroke. Arch Neurol 2004;61:889-92
46. Farswar M, Rathod SP, Upaganlawer AB, Semwal A. Protective effect of coenzyme Q10 in simvastatin and gemfibrozil induced rhabdomyolysis in rats. Indian J Exp Biol 2005;43:845-8
47. Stocker R, Pollicino C, Gay CA, et al. Neither plasma coenzyme Q10 concentration, nor its decline during pravastatin therapy, is linked to recurrent cardiovascular disease events: a prospective case-control study from the LIPID study. Atherosclerosis 2006;187:198-204
48. Kinlaw WB, Levine AS, Morley JE, Silvis SE, McClain CJ. Abnormal zinc metabolism in type II diabetes mellitus. Am J Med 1983;75:273-7
49. Singh RB, Niaz MA, Ahmed S, Rastogi SS, Singh U, Agarwal P. Dietary and serum levels of antioxidant minerals in patients with acute myocardial infarction. Trace Elem Elect 1995;12:148-52